Dr. Ali Masud, MD

Dr. Masud practices at Texas Children's Hospital - Mfm the Methodist Hospital - HOPD in Houston, Texas.

Dr. Masud's NPI, 1952588535, was assigned on January 26, 2008. Dr. Masud graduated from King Edward Medical University in 2001. Dr. Masud holds Texas license Q5696.

Dr. Masud's primary practice is Texas Children's Hospital - Mfm the Methodist Hospital - HOPD, at 6550 Fannin St, Houston, TX 77030.

Dr. Masud's primary practice is Texas Children's Hospital - Mfm the Methodist Hospital - HOPD in Houston, Texas. Dr. Masud is also affiliated with Houston Methodist Hospital. The medical group on file is Houston Methodist Specialty Physician Group. Dmand AI also links Dr. Masud to 2 more hospitals, 6 medical groups and 3 group practices and clinics, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Masud practices, 7 sites in all. Vendor and product names are available with a free account.

Interventional cardiology is Dr. Masud's primary specialty in the NPI Registry, under taxonomy code 207RI0011X. Dr. Masud is board certified in cardiovascular disease by the American Board of Internal Medicine. Dmand AI has Dr. Masud's licenses on file in 2 states: Texas and New York.

Dmand AI lists angioplasty and cardiac catheterization among the conditions Dr. Masud treats.

CMS data shows 2,035 Medicare services from Dr. Masud across 25 procedure codes in 2024, for 621 Medicare patients. Medicare paid $191,611 for them.

CMS counts 621 Medicare patients who saw Dr. Masud in 2024. The largest group is 65 to 74, with 300 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 3% are also on Medicaid. Their average risk score is 1.68, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Masud's median patient age at 75, with 48% women.

In 2024, Dr. Masud wrote 3,980 Medicare Part D claims for 635 patients. 88% of them were for generic drugs. CMS names the drug for 3,755 of them, across 33 drugs with 11 or more claims each, at $409,691 in total drug cost. In 2023, CMS named 2,223 claims across 27 drugs.

Dr. Masud accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 43 procedures of coronary angioplasty and stenting by Dr. Masud, more than 79% of the clinicians it reports for that procedure.

Dmand AI links 11 papers to Dr. Masud, published from 2007 to 2023. 2021 was the busiest year, with 3. The most frequent topics are Apoptosis, Caspase 3 and Caspase 7. Dr. Masud has published most often in ACS Appl Mater Interfaces. Dr. Masud's most frequent co-authors are Irteza Bin Inayat, MD, Saquib Ali Lakhani, MD and Christopher Michael Stafford, MD.

CMS Open Payments shows 454 general payments to Dr. Masud from 57 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 75% of the total. Medtronic, Inc. paid the most, $3,561.

Dmand AI lists 1 award for Dr. Masud.

Dr. Masud graduated from King Edward Medical University in 2001. Dr. Masud is a member of ACC.

Dr. Masud is in network with 17 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.